Zentalis Pharmaceuticals, Inc. (ZNTL)

Last Three Months

26-Jan-24 -- 25-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

12

0

6

+1

0

+2

0

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Feb-24 8:22 PM View:	12-Feb-24 Sale (Planned) ($29.44K)	Epperly Melissa B, Chief Financial Officer		Zentalis Pharmaceuticals, Inc. - ZNTL	16% 387.69K to 451.45K	0	0	--	--	Show Txns Hide Txns

12-Feb-24 8:21 PM View:	12-Feb-24 Sale (Planned) ($13.42K)	Gallagher Cam President Director		Zentalis Pharmaceuticals, Inc. - ZNTL	39% 463.5K to 643.28K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:11 PM View:	01-Feb-24 Payment of Exercise ($241.46K)	Blackwell Kimberly Chief Executive Officer Director		Zentalis Pharmaceuticals, Inc. - ZNTL	90% 254.8K to 484.14K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:15 PM View:	02-Feb-24 Sale ($18.29K)	Lackner Mark Chief Scientific Officer		Zentalis Pharmaceuticals, Inc. - ZNTL	248% 56.31K to 195.73K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:14 PM View:	02-Feb-24 Sale ($38.20K)	Paul Andrea Chief Legal Officer		Zentalis Pharmaceuticals, Inc. - ZNTL	268% 40.78K to 149.97K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:16 PM View:	01-Feb-24 Grant 0	Hausman Diane Chief Medical Officer		Zentalis Pharmaceuticals, Inc. - ZNTL	849% 39.73K to 377.23K	0	0	--	--	Show Txns Hide Txns